# The Effect of Fluticasone/Salmeterol Combination on Exertional Breathlessness in Patients With Mild COPD

> **NCT00559312** · NA · COMPLETED · sponsor: **Queen's University** · enrollment: 18 (actual)

## Conditions studied

- COPD

## Interventions

- **DRUG:** fluticasone/salmeterol combination
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00559312
- **Lead sponsor:** Queen's University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2010-03
- **Final completion:** 2010-04
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2012-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00559312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00559312, "The Effect of Fluticasone/Salmeterol Combination on Exertional Breathlessness in Patients With Mild COPD". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00559312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*